![Frontiers | Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends Frontiers | Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends](https://www.frontiersin.org/files/Articles/866889/fonc-12-866889-HTML/image_m/fonc-12-866889-g001.jpg)
Frontiers | Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends
![Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial | Journal of Clinical Oncology Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2013.51.34.issue-10/jco.2015.62.1797/20190110/images/medium/jco621797t1.jpeg)
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial | Journal of Clinical Oncology
![PDF) Re)Producing Medical Anthropology in Central and Eastern Europe | Valentin-Veron Toma - Academia.edu PDF) Re)Producing Medical Anthropology in Central and Eastern Europe | Valentin-Veron Toma - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/83331401/mini_magick20220406-15988-x29oqb.png?1649262944)